Practo demonstrated a remarkable 90% increase in EBITDA compared to FY23, alongside a 22% revenue growth. The company’s strategic focus on its core operations resulted in a 68% Compound Annual Growth Rate (CAGR), significantly narrowing its adjusted negative EBITDA from Rs 162 crore to Rs 17 crore. Moreover, contribution margins surged to 40% in FY24 from -1% in FY22, underscoring substantial improvements in operational efficiency.
Practo’s primary operations encompass software solutions, appointment scheduling, and telemedicine, all of which are now profitable and yield robust cash flows. Over the past year, notable growth has been observed in Tier II and III markets, with revenues in these regions increasing by 50%, while Tier I markets saw a 20% growth. Furthermore, its hospital management system, Insta, enjoys widespread trust among more than 1,500 healthcare facilities worldwide, commanding a 15% market share in the UAE and boasting a retention rate of 98%, while maintaining positive cash flow. Practo’s B2C segment accounts for approximately 80-85% of its total revenue, with its healthcare platform serving as the cornerstone of its operations. Additionally, the company is actively expanding its comprehensive vertical, encompassing telemedicine, specialized healthcare procedures, and co-branded clinics.